|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Badve S, Dabbs DJ, Schnitt SJ, Baehner FL,
Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR,
et al: Basal-like and triple-negative breast cancers: A critical
review with an emphasis on the implications for pathologists and
oncologists. Mod Pathol. 24:157–167. 2011. View Article : Google Scholar
|
|
3
|
Haupt B, Ro JY and Schwartz MR: Basal-like
breast carcinoma: A phenotypically distinct entity. Arch Pathol Lab
Med. 134:130–133. 2010.PubMed/NCBI
|
|
4
|
Rakha E and Reis-Filho JS: Basal-like
breast carcinoma: From expression profiling to routine practice.
Arch Pathol Lab Med. 133:860–868. 2009.PubMed/NCBI
|
|
5
|
Silva F, Carvalho S, Milanezi F and
Schmitt FC: Basal-like carcinoma of the breast. Acta Med Port.
21:373–378. 2008.(In Portuguese). PubMed/NCBI
|
|
6
|
Su CM, Wang MY, Hong CC, et al: miR-520h
is crucial for DAPK2 regulation and breast cancer progression.
Oncogene. 2015.
|
|
7
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmittgen TD: Regulation of microRNA
processing in development, differentiation and cancer. J Cell Mol
Med. 12:1811–1819. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vilquin P, Donini CF, Villedieu M, Grisard
E, Corbo L, Bachelot T, Vendrell JA and Cohen PA: MicroRNA-125b
upregulation confers aromatase inhibitor resistance and is a novel
marker of poor prognosis in breast cancer. Breast Cancer Res.
17:132015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu Y, Xu K and Yagüe E: miR-218 targets
survivin and regulates resistance to chemotherapeutics in breast
cancer. Breast Cancer Res Treat. 151:269–280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu R, Liu C, Chen D, Yang WH, Liu X, Liu
CG, Dugas CM, Tang F, Zheng P, Liu Y, et al: FOXP3 controls a
miR-146/NF-κB negative feedback loop that inhibits apoptosis in
breast cancer cells. Cancer Res. 75:1703–1713. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang G, Hou X, Li Y and Zhao M: MiR-205
inhibits cell apoptosis by targeting phosphatase and tensin homolog
deleted on chromosome ten in endometrial cancer Ishikawa cells. BMC
Cancer. 14:4402014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iorio MV, Casalini P, Piovan C, Di Leva G,
Merlo A, Triulzi T, Ménard S, Croce CM and Tagliabue E:
microRNA-205 regulates HER3 in human breast cancer. Cancer Res.
69:2195–2200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Verdoodt B, Neid M, Vogt M, Kuhn V,
Liffers ST, Palisaar RJ, Noldus J, Tannapfel A and
Mirmohammadsadegh A: MicroRNA-205, a novel regulator of the
anti-apoptotic protein Bcl2, is downregulated in prostate cancer.
Int J Oncol. 43:307–314. 2013.PubMed/NCBI
|
|
16
|
Matsushima K, Isomoto H, Yamaguchi N,
Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S,
Nagayasu T, et al: MiRNA-205 modulates cellular invasion and
migration via regulating zinc finger E-box binding homeobox 2
expression in esophageal squamous cell carcinoma cells. J Transl
Med. 9:302011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yue X, Wang P, Xu J, Zhu Y, Sun G, Pang Q
and Tao R: MicroRNA-205 functions as a tumor suppressor in human
glioblastoma cells by targeting VEGF-A. Oncol Rep. 27:1200–1206.
2012.
|
|
18
|
Chen Z, Tang ZY, He Y, Liu LF, Li DJ and
Chen X: miRNA-205 is a candidate tumor suppressor that targets ZEB2
in renal cell carcinoma. Oncol Res Treat. 37:658–664. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang
SZ, Ren XB and Cao S: MiR-205 in cancer: An angel or a devil? Eur J
Cell Biol. 92:54–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bureau C, Hanoun N, Torrisani J, Vinel JP,
Buscail L and Cordelier P: Expression and function of Kruppel
like-factors (KLF) in carcinogenesis. Curr Genomics. 10:353–360.
2009. View Article : Google Scholar :
|
|
21
|
Schuierer M, Hilger-Eversheim K, Dobner T,
Bosserhoff AK, Moser M, Turner J, Crossley M and Buettner R:
Induction of AP-2alpha expression by adenoviral infection involves
inactivation of the AP-2rep transcriptional corepressor CtBP1. J
Biol Chem. 276:27944–27949. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakamura Y, Migita T, Hosoda F, Okada N,
Gotoh M, Arai Y, Fukushima M, Ohki M, Miyata S, Takeuchi K, et al:
Kruppel-like factor 12 plays a significant role in poorly
differentiated gastric cancer progression. Int J Cancer.
125:1859–1867. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen X, Hu Y, Jiang Y, Liu H, Zhu L, Jin
X, Shan H, Zhen X, Sun L, Yan G, et al: Krüppel-like factor 12
negatively regulates human endometrial stromal cell
decidualization. Biochem Biophys Res Commun. 433:11–17. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bloom HJ: Complications following
radiotherapy of the thorax and abdomen. Proc R Soc Med. 52:495–500.
1959.PubMed/NCBI
|
|
25
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I The value of histological
grade in breast cancer: Experience from a large study with
long-term follow-up. Histopathology. 19:403–410. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Finn RS, Dering J, Ginther C, Wilson CA,
Glaspy P, Tchekmedyian N and Slamon DJ: Dasatinib, an orally active
small molecule inhibitor of both the src and abl kinases,
selectively inhibits growth of basal-type/'triple-negative' breast
cancer cell lines growing in vitro. Breast Cancer Res Treat.
105:319–326. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nielsen TO, Hsu FD, Jensen K, Cheang M,
Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler
L, et al: Immunohistochemical and clinical characterization of the
basal-like subtype of invasive breast carcinoma. Clin Cancer Res.
10:5367–5374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gene Ontology Consortium. The Gene
Ontology (GO) project in 2006. Nucleic Acids Res. 34:D322–D326.
2006. View Article : Google Scholar :
|
|
29
|
Blake JA and Harris MA: The Gene Ontology
(GO) project: structured vocabularies for molecular biology and
their application to genome and expression analysis. Curr Protoc
Bioinformatics. Chapter 7(Unit 7): 22008.PubMed/NCBI
|
|
30
|
Camon E, Magrane M, Barrell D, Binns D,
Fleischmann W, Kersey P, Mulder N, Oinn T, Maslen J, Cox A, et al:
The Gene Ontology Annotation (GOA) project: Implementation of GO in
SWISS-PROT, TrEMBL, and InterPro. Genome Res. 13:662–672. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo CJ, Pan Q, Li DG, Sun H and Liu BW:
miR-15b and miR-16 are implicated in activation of the rat hepatic
stellate cell: An essential role for apoptosis. J Hepatol.
50:766–778. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rajewsky N: microRNA target predictions in
animals. Nat Genet. 38(Suppl): S8–S13. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Storey JD and Tibshirani R: Statistical
significance for genomewide studies. Proc Natl Acad Sci USA.
100:9440–9445. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M,
et al: Combinatorial microRNA target predictions. Nat Genet.
37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human microRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Creighton CJ, Nagaraja AK, Hanash SM,
Matzuk MM and Gunaratne PH: A bioinformatics tool for linking gene
expression profiling results with public databases of microRNA
target predictions. RNA. 14:2290–2296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shalgi R, Lieber D, Oren M and Pilpel Y:
Global and local architecture of the mammalian
microRNA-transcription factor regulatory network. PLoS Comput Biol.
3:e1312007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
41
|
Ishihara A, Tsuda H, Kitagawa K, Yoneda M
and Shiraishi T: Morphological characteristics of basal-like
subtype of breast carcinoma with special reference to
cytopathological features. Breast Cancer. 16:179–185. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu H and Mo YY: Targeting miR-205 in
breast cancer. Expert Opin Ther Targets. 13:1439–1448. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Piovan C, Palmieri D, Di Leva G, Braccioli
L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi
T, et al: Oncosuppressive role of p53-induced miR-205 in triple
negative breast cancer. Mol Oncol. 6:458–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang S, Huang J, Lyu H, Lee CK, Tan J,
Wang J and Liu B: Functional cooperation of miR-125a, miR-125b, and
miR-205 in entinostat-induced downregulation of erbB2/erbB3 and
apoptosis in breast cancer cells. Cell Death Dis. 4:e5562013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kim JS, Yu SK, Lee MH, Park MG, Park E,
Kim SG, Lee SY, Kim CS, Kim HJ, Chun HS, et al: MicroRNA-205
directly regulates the tumor suppressor, interleukin-24, in human
KB oral cancer cells. Mol Cells. 35:17–24. 2013. View Article : Google Scholar
|
|
46
|
Zhang Q, Zhang H, Jiang Y, Xue B, Diao Z,
Ding L, Zhen X, Sun H, Yan G and Hu Y: MicroRNA-181a is involved in
the regulation of human endometrial stromal cell decidualization by
inhibiting Krüppel-like factor 12. Reprod Biol Endocrinol.
13:232015. View Article : Google Scholar
|
|
47
|
Bosher JM, Williams T and Hurst HC: The
developmentally regulated transcription factor AP-2 is involved in
c-erbB-2 over-expression in human mammary carcinoma. Proc Natl Acad
Sci USA. 92:744–747. 1995. View Article : Google Scholar
|
|
48
|
Moser M, Pscherer A, Roth C, Becker J,
Mücher G, Zerres K, Dixkens C, Weis J, Guay-Woodford L, Buettner R,
et al: Enhanced apoptotic cell death of renal epithelial cells in
mice lacking transcription factor AP-2beta. Genes Dev.
11:1938–1948. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gaubatz S, Imhof A, Dosch R, Werner O,
Mitchell P, Buettner R and Eilers M: Transcriptional activation by
Myc is under negative control by the transcription factor AP-2.
EMBO J. 14:1508–1519. 1995.PubMed/NCBI
|
